We’re Going Virtual!

We are reimagining the way we deliver conferences. Pathways To Access & Reimbursement (formerly PHARMA SYMPOSIUM) has changed format from a live, in-person event to an interactive, virtual conference.

Register Now with Early Bird Rate & Save

Bringing together manufacturers, regulators and payers to discuss developments impacting market entry, pricing and patient outcomes

Join Canada’s premier forum on navigating market entry and developing effective pricing strategies on January 21, 2021 in an interactive, virtual format.

Meet the Co-Chairs
Speaker Name

Alexis Sciuk

Director of Access & Government Relations

Speaker Name

Rosemarie Childerhose

Director, Market Access & Government Affairs
Bausch Health


Forecasting Future Pathways for Access in the Canadian Market

Preparing for PMPRB Final Guidelines: A Practical Examination of the Impact on Drug Pricing in Canada

Private Payers Panel: Approaches to Reimbursement for Advanced Therapeutics

  • BC Ministry of Health
  • CORD
  • Crohn’s & Colitis Canada
  • Canada Life
  • Green Shield Canada
  • Pfizer
Top Reasons to Attend
  • Get direction on the latest changes to drug reviews and pricing ceilings to better inform market access and pricing strategies
  • Gain insights on reimbursement regimes though Q & A with public and private payers
  • Walk away with an understanding of how to bring innovative solutions to market
  • Hear how other jurisdictions are approaching HTA and pricing negotiations
  • Learn about developments in precision medicine that could increase the safety and efficacy of treatments while reducing healthcare spending
Past Attending Organizations Include
  • Sidley & Austin LLP
  • Paladin Labs Inc
  • Boehringer Ingelheim Canada Ltd
  • Clinical Trials Ontario
  • Sun Life Financial
  • Green Shield Canada
  • PIVINA Consulting Inc
  • LifeLabs
  • Amgen Canada Inc
  • Pan-Canadian Pharmaceutical Alliance
  • Canopy Growth Corporation
  • Otsuka Canada Pharmaceutical Inc
  • Norton Rose Fulbright Canada LLP
  • GSK
  • Cancer Care Ontario
  • Bristol Myers Squibb
  • Cornerstone Research Group
  • Novartis Canada
  • Sandoz Canada Inc
  • Innovative Medicines Canada
  • Ipsen Biopharmaceuticals Canada
  • Equitable Life of Canada
  • SteriMax
  • Brougham Consulting Inc
  • Osler Hoskin & Harcourt LLP
  • Canadian Organization for Rare Disorders
  • Leslie Dan Faculty of Pharmacy
  • GlaxoSmithKline Plc
  • RWW Consultants
  • AstraZeneca Canada Inc
  • Innomar Strategies Inc
  • AbbVie Corporation
  • Great West Life
  • Jamp Pharma Corporation

Register now to attend this forward-looking forum, designed to bring clarity to some of the greatest challenges facing manufacturers, patients and payers alike.